5N Plus Inc. Stock

Equities

VNP

CA33833X1015

Specialty Chemicals

Market Closed - Toronto S.E. 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
4.69 CAD +0.21% Intraday chart for 5N Plus Inc. -1.68% +24.07%
Sales 2024 * 278M 380M Sales 2025 * 308M 421M Capitalization 304M 415M
Net income 2024 * 16M 21.85M Net income 2025 * 21M 28.68M EV / Sales 2024 * 1.36 x
Net Debt 2024 * 75.72M 103M Net Debt 2025 * 57.13M 78.03M EV / Sales 2025 * 1.17 x
P/E ratio 2024 *
16.3 x
P/E ratio 2025 *
12.2 x
Employees 780
Yield 2024 *
-
Yield 2025 *
-
Free-Float 95.2%
More Fundamentals * Assessed data
Dynamic Chart
Toronto Stocks Advance; Lithium Americas Shares Down on Discounted Pricing for $275 Million Public Offering DJ
5n Plus Up More Than 2% After US Department of Defense Awards It a US$14.4 Million Contract MT
5N Plus Brief: Says Awarded US$14.4 Million by U.S. Department of Defense MT
5N Plus Inc. Wins Usd 14.4 Million by U.S. Department of Defense CI
National Bank Raises 5N Plus Target to $6, Reiterates Outperform MT
5N+ Says Patents "Uniquely Positioned" to Expedite First-to-Market Commercialization of Vertical GaN-on-Si Power Devices MT
5N Plus Inc. Launches the Commercialization Rights for Its Portfolio of Gallium Nitride on Silicon (Gan-On-Si) Patents CI
National Bank Reviews 5N Plus' Q4 Results MT
Transcript : 5N Plus Inc., Q4 2023 Earnings Call, Feb 28, 2024
North American Morning Briefing : Stock Futures Fall Ahead of Key Inflation Data DJ
5N Plus Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
5N Plus Inc. Reports Impairment Results for the Fourth Quarter of 2023 CI
5N Plus Brief: Record reported Adjusted EBITDA of US$38.3 million in FY 2023; Adjusted gross margin of 29.0% for FY 2023; Net debt to EBITDA ratio of 1.69x as at December 31, 2023 MT
5N Plus Brief: Net earnings of US$2.3 million in Q4 2023 and $15.4 million in FY 2023 MT
North American Morning Briefing : Stock Futures Pause as Investors Eye Inflation Data DJ
More news
1 day+0.21%
1 week-1.68%
Current month-6.20%
1 month-3.30%
3 months+26.08%
6 months+43.87%
Current year+24.07%
More quotes
1 week
4.57
Extreme 4.57
5.00
1 month
4.54
Extreme 4.54
5.13
Current year
3.33
Extreme 3.33
5.13
1 year
2.86
Extreme 2.86
5.13
3 years
1.03
Extreme 1.03
5.13
5 years
1.01
Extreme 1.01
5.13
10 years
0.92
Extreme 0.92
5.13
More quotes
Managers TitleAgeSince
Chief Executive Officer - 20-04-30
Director of Finance/CFO 51 14-03-16
Corporate Officer/Principal - 17-02-19
Members of the board TitleAgeSince
Director/Board Member 73 07-12-31
Director/Board Member 61 14-04-30
Chairman 73 16-01-10
More insiders
Date Price Change Volume
24-04-25 4.69 +0.21% 25,763
24-04-24 4.68 -1.68% 51,838
24-04-23 4.76 -2.46% 36,406
24-04-22 4.88 +5.17% 258,904
24-04-19 4.64 -2.73% 60,290

Delayed Quote Toronto S.E., April 25, 2024 at 04:00 pm EDT

More quotes
5N Plus Inc. is a global producer of specialty semiconductors and performance materials. The Company deploys a range of technologies to develop and manufacture its products. It operates through two segments: Specialty Semiconductors and Performance Materials. Operating in North America and Europe, the Specialty Semiconductors segment manufactures and sells products used in several applications, such as renewable energy, space satellites and imaging. Its end markets include photovoltaics (terrestrial and spatial solar energy), medical imaging, infrared imaging, optoelectronics, and advanced electronics. The Performance Materials segment operates in North America, Europe and Asia and manufactures and sells products that are used in several applications in pharmaceutical and healthcare, industrial, and extractive and catalytic. Main products are sold as active pharmaceutical ingredients, animal feed additives, specialized chemicals, commercial grade metals, alloys, and engineered powders.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.424 USD
Average target price
4.356 USD
Spread / Average Target
+27.25%
Consensus